$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Oxidized LDL and HDL: antagonists in atherothrombosis

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, v.15 no.12, 2001년, pp.2073 - 2084  

Mertens, Ann (Center for Experimental Surgery and AnesthesiologyKatholieke Universiteit LeuvenBelgium) ,  Holvoet, Paul (Center for Experimental Surgery and AnesthesiologyKatholieke Universiteit LeuvenBelgium)

Abstract AI-Helper 아이콘AI-Helper

Increased LDL oxidation is associated with coronary artery disease. The predictive value of circulating oxidized LDL is additive to the Global Risk Assessment Score for cardiovascular risk prediction based on age, gender, total and HDL cholesterol, diabetes, hypertension, and smoking. Circulating ox...

참고문헌 (135)

  1. 10.1016/0076-6879(86)28061-1 

  2. J. Lipid Res. Ramos P. 2113 36 1995 10.1016/S0022-2275(20)39196-3 Effect of temperature and phase transition on oxidation resistance of low density lipoprotein 

  3. Heinecke, Jay W.. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis :. Current opinion in lipidology, vol.8, no.5, 268-274.

  4. Parthasarathy, S, Wieland, E, Steinberg, D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.. Proceedings of the National Academy of Sciences of the United States of America, vol.86, no.3, 1046-1050.

  5. J. Immunol. McNally A. K. 254 145 1990 10.4049/jimmunol.145.1.254 Activated human monocytes oxidize low density lipoprotein by a lipoxygenase‐dependent pathway 

  6. J. Lipid Res. Rankin S. M. 449 32 1991 10.1016/S0022-2275(20)42068-1 Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages 

  7. Harats, Dror, Shaish, Aviv, George, Jacob, Mulkins, Mary, Kurihara, Hiroki, Levkovitz, Hana, Sigal, Elliott. Overexpression of 15-Lipoxygenase in Vascular Endothelium Accelerates Early Atherosclerosis in LDL Receptor-Deficient Mice. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.9, 2100-2105.

  8. Cyrus, Tillmann, Witztum, Joseph L., Rader, Daniel J., Tangirala, Rajendra, Fazio, Sergio, Linton, MacRae F., Funk, Colin D.. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. The Journal of clinical investigation, vol.103, no.11, 1597-1604.

  9. 10.1007/978-1-4615-4793-8_67 

  10. Carr, Anitra C., McCall, Mark R., Frei, Balz. Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species : Reaction Pathways and Antioxidant Protection. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.7, 1716-1723.

  11. Podrez, Eugene A., Schmitt, David, Hoff, Henry F., Hazen, Stanley L.. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. The Journal of clinical investigation, vol.103, no.11, 1547-1560.

  12. Malle, Ernst, Waeg, Georg, Schreiber, Renate, Gröne, Elisabeth F., Sattler, Wolfgang, Gröne, Hermann‐Josef. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions. European journal of biochemistry, vol.267, no.14, 4495-4503.

  13. Heller, Jozsef I., Crowley, Jan R., Hazen, Stanley L., Salvay, David M., Wagner, Peter, Pennathur, Subramaniam, Heinecke, Jay W.. p-Hydroxyphenylacetaldehyde, an Aldehyde Generated by Myeloperoxidase, Modifies Phospholipid Amino Groups of Low Density Lipoprotein in Human Atherosclerotic Intima. The Journal of biological chemistry, vol.275, no.14, 9957-9962.

  14. Sugiyama, Seigo, Okada, Yoshikatsu, Sukhova, Galina K., Virmani, Renu, Heinecke, Jay W., Libby, Peter. Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary Syndromes. The American journal of pathology, vol.158, no.3, 879-891.

  15. Brennan, Marie-Luise, Anderson, Melissa M., Shih, Diana M., Qu, Xiao-Dan, Wang, Xuping, Mehta, Asha C., Lim, Lesley L., Shi, Weibin, Hazen, Stanley L., Jacob, Jason S., Crowley, Jan R., Heinecke, Jay W., Lusis, Aldons J.. Increased atherosclerosis in myeloperoxidase-deficient mice. The Journal of clinical investigation, vol.107, no.4, 419-430.

  16. J. Cell. Physiol. Guo J. P. 774 81 1996 Direct measurement of nitric oxide release from vascular endothelial cells 

  17. Rikitake, Yoshiyuki, Hirata, Ken-ichi, Kawashima, Seinosuke, Akita, Hozuka, Yokoyama, Mitsuhiro. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells. Atherosclerosis, vol.136, no.1, 51-57.

  18. Malo-Ranta, U., Yla-Herttuala, S., Metsa-Ketela, T., Jaakkola, O., Moilanen, E., Vuorinen, P., Nikkari, T.. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS letters, vol.337, no.2, 179-183.

  19. Carr, Anitra C., Frei, Balz. The Nitric Oxide Congener Nitrite Inhibits Myeloperoxidase/H2O2/ Cl−-mediated Modification of Low Density Lipoprotein. The Journal of biological chemistry, vol.276, no.3, 1822-1828.

  20. Patel, R P, Levonen, A, Crawford, J H, Darley-Usmar, V M. Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis.. Cardiovascular research, vol.47, no.3, 465-474.

  21. Laursen, Jørn Bech, Somers, Mark, Kurz, Sabine, McCann, Louise, Warnholtz, Ascan, Freeman, Bruce A., Tarpey, Margaret, Fukai, Tohru, Harrison, David G.. Endothelial Regulation of Vasomotion in ApoE-Deficient Mice : Implications for Interactions Between Peroxynitrite and Tetrahydrobiopterin. Circulation, vol.103, no.9, 1282-1288.

  22. Esaki, Teiji, Hayashi, Toshio, Muto, Emiko, Kano, Hatsuyo, Kumar, Thakur Navin, Asai, Yukako, Sumi, Daigo, Iguchi, Akihisa. Expression of Inducible Nitric Oxide Synthase and Fas/Fas Ligand Correlates with the Incidence of Apoptotic Cell Death in Atheromatous Plaques of Human Coronary Arteries. Nitric oxide : biology and chemistry, vol.4, no.6, 561-571.

  23. Bloodsworth, Allison, O’Donnell, Valerie B., Freeman, Bruce A.. Nitric Oxide Regulation of Free Radical- and Enzyme-Mediated Lipid and Lipoprotein Oxidation. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.7, 1707-1715.

  24. Holvoet, Paul, Stassen, Jean-Marie, Van Cleemput, Johan, Collen, Désiré, Vanhaecke, Johan. Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology, vol.18, no.1, 100-107.

  25. Holvoet, Paul, Vanhaecke, Johan, Janssens, Stefaan, Van de Werf, Frans, Collen, Désiré. Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease. Circulation, vol.98, no.15, 1487-1494.

  26. Salonen, J.T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., Witztum, J.L.. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. The Lancet, vol.339, no.8798, 883-887.

  27. Lehtimäki, Terho, Lehtinen, Saara, Solakivi, Tiina, Nikkilä, Matti, Jaakkola, Olli, Jokela, Hannu, Ylä-Herttuala, Seppo, Luoma, Jukka S., Koivula, Timo, Nikkari, Tapio. Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology, vol.19, no.1, 23-27.

  28. Orchard, T J, Virella, G, Forrest, K Y, Evans, R W, Becker, D J, Lopes-Virella, M F. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.. Diabetes, vol.48, no.7, 1454-1458.

  29. Bergmark, C., Wu, R., Faire, U. de, Lefvert, A. K., Swedenborg, J.. Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL. Arteriosclerosis, thrombosis, and vascular biology, vol.15, no.4, 441-445.

  30. Uusitupa, Matti I.J., Niskanen, Leo, Luoma, Jukka, Vilja, Pekka, Mercuri, Michele, Rauramaa, Rainer, Ylä-Herttuala, Seppo. Autoantibodies Against Oxidized LDL Do Not Predict Atherosclerotic Vascular Disease in Non-Insulin-Dependent Diabetes Mellitus. Arteriosclerosis, thrombosis, and vascular biology, vol.16, no.10, 1236-1242.

  31. Atherosclerosis Vijver L. P. 245 122 1996 10.1016/0021-9150(95)05759-5 Autoantibodies against MDA‐LDL in subjects with severe and minor atherosclerosis and healthy population controls 

  32. Holvoet, Paul, Donck, Jan, Landeloos, Michèle, Brouwers, Els, Luijtens, Kristel, Arnout, Jozef, Lesaffre, Emmanuel, Vanrenterghem, Yves, Collen, Désiré. Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure. Thrombosis and haemostasis, vol.76, no.5, 663-669.

  33. Grundy, Scott M., Pasternak, Richard, Greenland, Philip, Smith Jr, Sidney, Fuster, Valentin. Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations : A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology. Circulation, vol.100, no.13, 1481-1492.

  34. Holvoet, Paul, Mertens, Ann, Verhamme, Peter, Bogaerts, Kris, Beyens, Guy, Verhaeghe, Raymond, Collen, Désiré, Muls, Erik, Van de Werf, Frans. Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology, vol.21, no.5, 844-848.

  35. Toshima, Shun-ichi, Hasegawa, Akira, Kurabayashi, Masahiko, Itabe, Hiroyuki, Takano, Tatsuya, Sugano, Jinpei, Shimamura, Kyoko, Kimura, Junji, Michishita, Ichiro, Suzuki, Toru, Nagai, Ryozo. Circulating Oxidized Low Density Lipoprotein Levels : A Biochemical Risk Marker for Coronary Heart Disease. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.10, 2243-2247.

  36. Kohno, Hiroaki, Sueshige, Nobuyuki, Oguri, Kazuhito, Izumidate, Hironobu, Masunari, Toshiyuki, Kawamura, Mizuho, Itabe, Hiroyuki, Takano, Tatsuya, Hasegawa, Akira, Nagai, Ryozo. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody. Clinical biochemistry, vol.33, no.4, 243-253.

  37. Holvoet, Paul, Van Cleemput, Johan, Collen, Désiré, Vanhaecke, Johan. Oxidized Low Density Lipoprotein Is a Prognostic Marker of Transplant-Associated Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.3, 698-702.

  38. Pietzsch, Jens. Measurement of 5-Hydroxy-2-aminovaleric Acid as a Specific Marker of Iron-Mediated Oxidation of Proline and Arginine Side-Chain Residues of Low-Density Lipoprotein Apolipoprotein B-100. Biochemical and biophysical research communications, vol.270, no.3, 852-857.

  39. Pietzsch, Jens, Lattke, Peter, Julius, Ulrich. Oxidation of Apolipoprotein B-100 in Circulating LDL Is Related to LDL Residence Time : In Vivo Insights From Stable-Isotope Studies. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.10,

  40. J. Lipid Res. Nigon F. 1741 32 1991 10.1016/S0022-2275(20)41629-3 Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor 

  41. de Graaf, J, Hak-Lemmers, H L, Hectors, M P, Demacker, P N, Hendriks, J C, Stalenhoef, A F. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.. Arteriosclerosis and thrombosis, vol.11, no.2, 298-306.

  42. Gardner, C D, Fortmann, S P, Krauss, R M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.. JAMA : the journal of the American Medical Association, vol.276, no.11, 875-881.

  43. Stampfer, M J, Krauss, R M, Ma, J, Blanche, P J, Holl, L G, Sacks, F M, Hennekens, C H. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.. JAMA : the journal of the American Medical Association, vol.276, no.11, 882-888.

  44. Lamarche, Benoiˆt, Tchernof, Andre´, Moorjani, Sital, Cantin, Bernard, Dagenais, Gilles R., Lupien, Paul J., Despre´s, Jean-Pierre. Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men : Prospective Results From the Que´bec Cardiovascular Study. Circulation, vol.95, no.1, 69-75.

  45. Lamarche, B, Tchernof, A, Mauriège, P, Cantin, B, Dagenais, G R, Lupien, P J, Després, J P. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.. JAMA : the journal of the American Medical Association, vol.279, no.24, 1955-1961.

  46. Goldstein, Joseph L., Ho, Y. K., Basu, Sandip K., Brown, Michael S.. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proceedings of the National Academy of Sciences of the United States of America, vol.76, no.1, 333-337.

  47. Am. J. Pathol. Clinton S. K. 301 140 1992 Macrophage colony‐stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis 

  48. Horvai, Andrew E., Xu, Lan, Korzus, Edward, Brard, Gyan, Kalafus, Daniel, Mullen, Tina-Marie, Rose, David W., Rosenfeld, Michael G., Glass, Christopher K.. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proceedings of the National Academy of Sciences of the United States of America, vol.94, no.4, 1074-1079.

  49. J. Biol. Chem. Bottalico L. A. 22866 266 1991 10.1016/S0021-9258(18)54434-3 Transforming growth factor‐beta 1 inhibits scavenger receptor activity in THP‐1 human macrophages 

  50. Schreyer, Sandra A., Peschon, Jacques J., LeBoeuf, Renee C.. Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55. The Journal of biological chemistry, vol.271, no.42, 26174-26178.

  51. Ricote, Mercedes, Li, Andrew C., Willson, Timothy M., Kelly, Carolyn J., Glass, Christopher K.. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature, vol.391, no.6662, 79-82.

  52. Li, H, Freeman, M W, Libby, P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines.. The Journal of clinical investigation, vol.95, no.1, 122-133.

  53. Jovinge, Stefan, Hultgårdh-Nilsson, Anna, Regnström, Jan, Nilsson, Jan. Tumor Necrosis Factor-α Activates Smooth Muscle Cell Migration in Culture and Is Expressed in the Balloon-Injured Rat Aorta. Arteriosclerosis, thrombosis, and vascular biology, vol.17, no.3, 490-497.

  54. J. Lipid Res. Calvo D. 777 39 1998 10.1016/S0022-2275(20)32566-9 Human CD36 is a high affinity receptor for the native lipoproteins HDL. LDL, and VLDL 

  55. Podrez, Eugene A., Febbraio, Maria, Sheibani, Nader, Schmitt, David, Silverstein, Roy L., Hajjar, David P., Cohen, Peter A., Frazier, William A., Hoff, Henry F., Hazen, Stanley L.. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. The Journal of clinical investigation, vol.105, no.8, 1095-1108.

  56. Febbraio, Maria, Podrez, Eugene A., Smith, Jonathan D., Hajjar, David P., Hazen, Stanley L., Hoff, Henry F., Sharma, Kavita, Silverstein, Roy L.. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. The Journal of clinical investigation, vol.105, no.8, 1049-1056.

  57. Yoshida, Hiroshi, Quehenberger, Oswald, Kondratenko, Nonna, Green, Simone, Steinberg, Daniel. Minimally Oxidized Low-Density Lipoprotein Increases Expression of Scavenger Receptor A, CD36, and Macrosialin in Resident Mouse Peritoneal Macrophages. Arteriosclerosis, thrombosis, and vascular biology, vol.18, no.5, 794-802.

  58. Sawamura, Tatsuya, Kume, Noriaki, Aoyama, Takuma, Moriwaki, Hideaki, Hoshikawa, Hajime, Aiba, Yuichi, Tanaka, Takeshi, Miwa, Soichi, Katsura, Yoshimoto, Kita, Toru, Masaki, Tomoh. An endothelial receptor for oxidized low-density lipoprotein. Nature, vol.386, no.6620, 73-77.

  59. Kume, Noriaki, Murase, Takatoshi, Moriwaki, Hideaki, Aoyama, Takuma, Sawamura, Tatsuya, Masaki, Tomoh, Kita, Toru. Inducible Expression of Lectin-like Oxidized LDL Receptor-1 in Vascular Endothelial Cells. Circulation research : a journal of the American Heart Association, vol.83, no.3, 322-327.

  60. Murase, Takatoshi, Kume, Noriaki, Korenaga, Risa, Ando, Joji, Sawamura, Tatsuya, Masaki, Tomoh, Kita, Toru. Fluid Shear Stress Transcriptionally Induces Lectin-like Oxidized LDL Receptor-1 in Vascular Endothelial Cells. Circulation research : a journal of the American Heart Association, vol.83, no.3, 328-333.

  61. Nagase, Miki, Ando, Katsuyuki, Nagase, Takashi, Kaname, Shinya, Sawamura, Tatsuya, Fujita, Toshiro. Redox-Sensitive Regulation of LOX-1 Gene Expression in Vascular Endothelium. Biochemical and biophysical research communications, vol.281, no.3, 720-725.

  62. KUME, NORIAKI, MORIWAKI, HIDEAKI, KATAOKA, HIROHARU, MINAMI, MANABU, MURASE, TAKATOSHI, SAWAMURA, TATSUYA, MASAKI, TOMOH, KITA, TORU. Inducible Expression of LOX‐1, a Novel Receptor for Oxidized LDL, in Macrophages and Vascular Smooth Muscle Cells. Annals of the New York Academy of Sciences, vol.902, no.1, 323-327.

  63. Aoyama, Takuma, Chen, Mingyi, Fujiwara, Hisayoshi, Masaki, Tomoh, Sawamura, Tatsuya. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS letters, vol.467, no.2, 217-220.

  64. Minami, Manabu, Kume, Noriaki, Kataoka, Hiroharu, Morimoto, Masafumi, Hayashida, Kazutaka, Sawamura, Tatsuya, Masaki, Tomoh, Kita, Toru. Transforming Growth Factor-β1 Increases the Expression of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1. Biochemical and biophysical research communications, vol.272, no.2, 357-361.

  65. Cominacini, Luciano, Garbin, Ulisse, Pasini, Anna Fratta, Davoli, Anna, Campagnola, Mario, Contessi, Giovanni B, Pastorino, Antonio M, Lo Cascio, Vincenzo. Antioxidants Inhibit the Expression of Intercellular Cell Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 Induced by Oxidized LDL on Human Umbilical Vein Endothelial Cells. Free radical biology & medicine, vol.22, no.1, 117-127.

  66. Watson, Andrew D., Leitinger, Norbert, Navab, Mohamad, Faull, Kym F., Hörkkö, Sohvi, Witztum, Joseph L., Palinski, Wulf, Schwenke, Dawn, Salomon, Robert G., Sha, Wei, Subbanagounder, Ganesamoorthy, Fogelman, Alan M., Berliner, Judith A.. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo. The Journal of biological chemistry, vol.272, no.21, 13597-13607.

  67. Subbanagounder, Ganesamoorthy, Leitinger, Norbert, Shih, Peggy T., Faull, Kym F., Berliner, Judith A.. Evidence That Phospholipid Oxidation Products and/or Platelet-Activating Factor Play an Important Role in Early Atherogenesis : In Vitro and In Vivo Inhibition by WEB 2086. Circulation research : a journal of the American Heart Association, vol.85, no.4, 311-318.

  68. Proc. Natl. Acad. Sci. USA Leitinger N. 12010 96 2015 10.1073/pnas.96.21.12010 Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils 

  69. Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., Lusis, A. J.. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature, vol.344, no.6263, 254-257.

  70. Marathe, Sudhir, Kuriakose, George, Williams, Kevin Jon, Tabas, Ira. Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix. Arteriosclerosis, thrombosis, and vascular biology, vol.19, no.11, 2648-2658.

  71. Leitinger, Norbert, Watson, Andrew D., Hama, Susan Y., Ivandic, Boris, Qiao, Jian-Hua, Huber, Joakim, Faull, Kym F., Grass, David S., Navab, Mohamad, Fogelman, Alan M., de Beer, Frederick C., Lusis, Aldons J., Berliner, Judith A.. Role of Group II Secretory Phospholipase A 2 in Atherosclerosis : 2. Potential Involvement of Biologically Active Oxidized Phospholipids. Arteriosclerosis, thrombosis, and vascular biology, vol.19, no.5, 1291-1298.

  72. Ivandic, Boris, Castellani, Lawrence W., Wang, Xu-Ping, Qiao, Jian-Hua, Mehrabian, Margarete, Navab, Mohamad, Fogelman, Alan M., Grass, David S., Swanson, Mark E., de Beer, Maria C., de Beer, Frederick, Lusis, Aldons J.. Role of Group II Secretory Phospholipase A2in Atherosclerosis : 1. Increased Atherogenesis and Altered Lipoproteins in Transgenic Mice Expressing Group IIa Phospholipase A2. Arteriosclerosis, thrombosis, and vascular biology, vol.19, no.5, 1284-1290.

  73. Upston, Joanne M., Neužil, Jiřı́, Witting, Paul K., Alleva, Renata, Stocker, Roland. Oxidation of Free Fatty Acids in Low Density Lipoprotein by 15-Lipoxygenase Stimulates Nonenzymic, α-Tocopherol-mediated Peroxidation of Cholesteryl Esters. The Journal of biological chemistry, vol.272, no.48, 30067-30074.

  74. Anthonsen, Marit W., Stengel, Dominique, Hourton, Delphine, Ninio, Ewa, Johansen, Berit. Mildly Oxidized LDL Induces Expression of Group IIa Secretory Phospholipase A 2 in Human Monocyte-Derived Macrophages. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.5, 1276-1282.

  75. Cushing, S D, Berliner, J A, Valente, A J, Territo, M C, Navab, M, Parhami, F, Gerrity, R, Schwartz, C J, Fogelman, A M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.. Proceedings of the National Academy of Sciences of the United States of America, vol.87, no.13, 5134-5138.

  76. Li, Dayuan, Mehta, Jawahar L.. Upregulation of Endothelial Receptor for Oxidized LDL (LOX-1) by Oxidized LDL and Implications in Apoptosis of Human Coronary Artery Endothelial Cells : Evidence From Use of Antisense LOX-1 mRNA and Chemical Inhibitors. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.4, 1116-1122.

  77. Newby, Andrew C., George, Sarah J.. Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis :. Current opinion in cardiology, vol.11, no.6, 574-582.

  78. Newby, A.C., Zaltsman, A.B.. Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovascular research, vol.41, no.2, 345-360.

  79. Stiko-Rahm, A, Hultgårdh-Nilsson, A, Regnström, J, Hamsten, A, Nilsson, J. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.. Arteriosclerosis and thrombosis, vol.12, no.9, 1099-1109.

  80. Kohno, Masakazu, Yokokawa, Koji, Yasunari, Kenichi, Minami, Mieko, Kano, Hiroaki, Hanehira, Takao, Yoshikawa, Junichi. Induction by Lysophosphatidylcholine, a Major Phospholipid Component of Atherogenic Lipoproteins, of Human Coronary Artery Smooth Muscle Cell Migration. Circulation, vol.98, no.4, 353-359.

  81. Kim, Jong G., Taylor, W.Robert, Parthasarathy, Sampath. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody. Atherosclerosis, vol.143, no.2, 335-340.

  82. Lindner, V, Lappi, D A, Baird, A, Majack, R A, Reidy, M A. Role of basic fibroblast growth factor in vascular lesion formation.. Circulation research : a journal of the American Heart Association, vol.68, no.1, 106-113.

  83. Koba, Shinji, Pakala, Rajbabu, Katagiri, Takashi, Benedict, Claude R. Hyperlipemic-very low density lipoprotein, intermediate density lipoprotein and low density lipoprotein act synergistically with serotonin on vascular smooth muscle cell proliferation. Atherosclerosis, vol.149, no.1, 61-67.

  84. Liao, James K., Shin, Wee Soo, Lee, Wen Yee, Clark, Stephen L.. Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase. The Journal of biological chemistry, vol.270, no.1, 319-324.

  85. Vidal, Francisco, Colomé, Cristina, Martínez‐González, José, Badimon, Lina. Atherogenic concentrations of native low‐density lipoproteins down‐regulate nitric‐oxide‐synthase mRNA and protein levels in endothelial cells. European journal of biochemistry, vol.252, no.3, 378-384.

  86. Boulanger, C M, Tanner, F C, Béa, M L, Hahn, A W, Werner, A, Lüscher, T F. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium.. Circulation research : a journal of the American Heart Association, vol.70, no.6, 1191-1197.

  87. Kockx, Mark M.. Apoptosis in the Atherosclerotic Plaque : Quantitative and Qualitative Aspects. Arteriosclerosis, thrombosis, and vascular biology, vol.18, no.10, 1519-1522.

  88. J. Am. Soc. Nephrol. Heermeier K. 456 12 2001 10.1681/ASN.V123456 Oxidized LDL suppresses NF‐kappaB and overcomes protection from apoptosis in activated endothelial cells 

  89. Metzler, B., Hu, Y., Dietrich, H., Xu, Q.. Increased Expression and Activation of Stress-Activated Protein Kinases/c-Jun NH2-Terminal Protein Kinases in Atherosclerotic Lesions Coincide with p53. The American journal of pathology, vol.156, no.6, 1875-1886.

  90. Napoli, Claudio, Quehenberger, Oswald, De Nigris, Filomena, Abete, Pasquale, Glass, Christopher K., Palinski, Wulf. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.14, no.13, 1996-2007.

  91. Farber, Alik, Kitzmiller, Tamar, Morganelli, Peter M., Pfeiffer, Jason, Groveman, Debra, Wagner, Robert J., Cronenwett, Jack L., Powell, Richard J.. A Caspase Inhibitor Decreases Oxidized Low-Density Lipoprotein-Induced Apoptosis in Bovine Endothelial Cells. The Journal of surgical research, vol.85, no.2, 323-330.

  92. Holvoet, Paul, Collen, Désiré. Thrombosis and atherosclerosis :. Current opinion in lipidology, vol.8, no.5, 320-328.

  93. Thorin, E, Hamilton, C A, Dominiczak, M H, Reid, J L. Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release.. Arteriosclerosis and thrombosis, vol.14, no.3, 453-459.

  94. Li, Li-Xin, Chen, Jian-Xiong, Liao, Duan-Fang, Yu, Lin. Probucol Inhibits Oxidized-Low Density Lipoprotein-Induced Adhesion of Monocytes to Endothelial Cells by Reducing P-Selectin Synthesisin Vitro. Endothelium : journal of endothelial cell research, vol.6, no.1, 1-8.

  95. Armstrong, D.A.. Oxidized LDL, ceroid, and prostaglandin metabolism in human atherosclerosis. Medical hypotheses, vol.38, no.3, 244-248.

  96. J. Lipid Res. Frei B. 2135 34 1993 10.1016/S0022-2275(20)35354-2 Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion‐dependent and ‐independent oxidation 

  97. Penn, Marc S., Cui, Mei-Zhen, Winokur, Allison L., Bethea, John, Hamilton, Thomas A., DiCorleto, Paul E., Chisolm, Guy M.. Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation. Blood, vol.96, no.9, 3056-3063.

  98. Ishii, Hidemi, Kizaki, Keiichiro, Horie, Shuichi, Kazama, Mutsuyoshi. Oxidized Low Density Lipoprotein Reduces Thrombomodulin Transcription in Cultured Human Endothelial Cells through Degradation of the Lipoprotein in Lysosomes. The Journal of biological chemistry, vol.271, no.14, 8458-8465.

  99. Wilson, B D, Pitas, R E, Rodgers, G M. Regulation of endothelial cell protein C activation by native and oxidized low density lipoprotein.. Seminars in thrombosis and hemostasis, vol.18, no.1, 11-17.

  100. Petit, Laure, Lesnik, Philippe, Dachet, Christiane, Moreau, Martine, Chapman, M. John. Tissue Factor Pathway Inhibitor Is Expressed by Human Monocyte-Derived Macrophages : Relationship to Tissue Factor Induction by Cholesterol and Oxidized LDL. Arteriosclerosis, thrombosis, and vascular biology, vol.19, no.2, 309-315.

  101. Kugiyama, K, Sakamoto, T, Misumi, I, Sugiyama, S, Ohgushi, M, Ogawa, H, Horiguchi, M, Yasue, H. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells.. Circulation research : a journal of the American Heart Association, vol.73, no.2, 335-343.

  102. Gräfe, Michael, Auch-Schwelk, Wolfgang, Hertel, Hartmut, Terbeek, Dirk, Steinheider, Gerhard, Loebe, Matthias, Fleck, Eckart. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis, vol.137, no.1, 87-95.

  103. Allison, Beth A., Nilsson, Lennart, Karpe, Fredrik, Hamsten, Anders, Eriksson, Per. Effects of Native, Triglyceride-Enriched, and Oxidatively Modified LDL on Plasminogen Activator Inhibitor-1 Expression in Human Endothelial Cells. Arteriosclerosis, thrombosis, and vascular biology, vol.19, no.5, 1354-1360.

  104. Xu, Xiao-Ping, Meisel, Simcha R., Ong, John M., Kaul, Sanjay, Cercek, Bojan, Rajavashisth, Tripathi B., Sharifi, Behrooz, Shah, Prediman K.. Oxidized Low-Density Lipoprotein Regulates Matrix Metalloproteinase-9 and Its Tissue Inhibitor in Human Monocyte-Derived Macrophages. Circulation, vol.99, no.8, 993-998.

  105. Castelli, W P, Garrison, R J, Wilson, P W, Abbott, R D, Kalousdian, S, Kannel, W B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.. JAMA : the journal of the American Medical Association, vol.256, no.20, 2835-2838.

  106. Rubins, Hanna Bloomfield, Robins, Sander J., Collins, Dorothea, Fye, Carol L., Anderson, James W., Elam, Marshall B., Faas, Fred H., Linares, Esteban, Schaefer, Ernst J., Schectman, Gordon, Wilt, Timothy J., Wittes, Janet. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol. The New England journal of medicine, vol.341, no.6, 410-418.

  107. Circulation Foody J. M. III90 102 2000 10.1161/01.CIR.102.suppl_3.III-90 HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20‐year experience from The Cleveland Clinic Foundation 

  108. J. Lipid Res. Navab M. 1495 41 2000 10.1016/S0022-2275(20)33462-3 Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3 

  109. J. Lipid Res. Navab M. 1481 41 2000 10.1016/S0022-2275(20)33461-1 Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1 

  110. MACKNESS, M, ARROL, S, ABBOTT, C, DURRINGTON, P. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis, vol.104, no.1, 129-135.

  111. Watson, A D, Berliner, J A, Hama, S Y, La Du, B N, Faull, K F, Fogelman, A M, Navab, M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.. The Journal of clinical investigation, vol.96, no.6, 2882-2891.

  112. Aviram, M, Rosenblat, M, Bisgaier, C L, Newton, R S, Primo-Parmo, S L, La Du, B N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.. The Journal of clinical investigation, vol.101, no.8, 1581-1590.

  113. Navab, M, Hama-Levy, S, Van Lenten, B J, Fonarow, G C, Cardinez, C J, Castellani, L W, Brennan, M L, Lusis, A J, Fogelman, A M, La Du, B N. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.. The Journal of clinical investigation, vol.99, no.8, 2005-2019.

  114. Hedrick, Catherine C., Hassan, Kholood, Hough, Greg P., Yoo, JiHyung, Simzar, Soheil, Quinto, Cindy R., Kim, Sul-Min, Dooley, Alek, Langi, Sesilia, Hama, Susan Y., Navab, Mohamad, Witztum, Joseph L., Fogelman, Alan M.. Short-Term Feeding of Atherogenic Diet to Mice Results in Reduction of HDL and Paraoxonase That May Be Mediated by an Immune Mechanism. Arteriosclerosis, thrombosis, and vascular biology, vol.20, no.8, 1946-1952.

  115. Shih, Diana M., Xia, Yu-Rong, Wang, Xu-Ping, Miller, Elizabeth, Castellani, Lawrence W., Subbanagounder, Ganesamoorthy, Cheroutre, Hilde, Faull, Kym F., Berliner, Judith A., Witztum, Joseph L., Lusis, Aldons J.. Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis. The Journal of biological chemistry, vol.275, no.23, 17527-17535.

  116. Vohl, M.-C., Neville, T. A.-M., Kumarathasan, R., Braschi, S., Sparks, D. L.. A Novel Lecithin-Cholesterol Acyltransferase Antioxidant Activity Prevents the Formation of Oxidized Lipids during Lipoprotein Oxidation. Biochemistry, vol.38, no.19, 5976-5981.

  117. J. Lipid Res. Bielicki J. K. 948 40 1999 10.1016/S0022-2275(20)32130-1 Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltrans‐ferase activity 

  118. J. Clin. Invest. Holvoet P. 379 102 1998 10.1172/JCI3038 Substitution of the carboxyl‐terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice 

  119. Ross, Russell. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, vol.362, no.6423, 801-809.

  120. Evangelou, A.M.. Platelet-activating factor (PAF): Implications for coronary heart and vascular diseases. Prostaglandins, leukotrienes, and essential fatty acids, vol.50, no.1, 1-28.

  121. IMAIZUMI, TADA‐ATSU, STAFFORINI, DIANA M., YAMADA, YOSHIJI, MCINTYRE, THOMAS M., PRESCOTT, STEPHEN M., ZIMMERMAN, GUY A.. Platelet‐activating factor: a mediator for clinicians. Journal of internal medicine, vol.238, no.1, 5-20.

  122. J. Biol. Chem. Stafforini D. M. 4215 262 1987 10.1016/S0021-9258(18)61335-3 Human plasma platelet‐activating factor acetylhy‐drolase. Association with lipoprotein particles and role in the degradation of platelet‐activating factor 

  123. Stafforini, Diana M., Prescott, Stephen M., Zimmerman, Guy A., McIntyre, Thomas M.. Platelet‐activating factor acetylhydrolase activity in human tissues and blood cells. Lipids, vol.26, no.12, 979-985.

  124. Tjoelker, Larry W., Wilder, Cheryl, Eberhardt, Chris, Stafforinit, Diana M., Dietsch, Greg, Schimpf, Brian, Hooper, Shawn, Trong, Hai Le, Cousens, Lawrence S., Zimmerman, Guy A., Yamadat, Yoshiji, Mclntyre, Thomas M., Prescott, Stephen M., Gray, Patrick W.. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature, vol.374, no.6522, 549-553.

  125. Tselepis, Alexandros D., Dentan, Christine, Karabina, Sonia-Athena P., Chapman, M. John, Ninio, Ewa. PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma : Catalytic Characteristics and Relation to the Monocyte-Derived Enzyme. Arteriosclerosis, thrombosis, and vascular biology, vol.15, no.10, 1764-1773.

  126. J. Lipid Mediat. Cell Signal. Tsaoussis V. 317 9 1994 The mouse plasma PAF acetylhydrolase: II. It consists of two enzymes both associated with the HDL 

  127. Theilmeier, Gregor, De Geest, Bart, Van Veldhoven, Paul P., Stengel, Dominique, Michiels, Carine, Lox, Marleen, Landeloos, Michele, Chapman, M. John, Ninio, Ewa, Collen, Désiré, Himpens, Bernard, Holvoet, Paul. HDLassociated PAF‐AH reduces endothelial adhesiveness in apoE−/−mice. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.14, no.13, 2032-2039.

  128. De Geest, Bart, Zhao, Zhian, Collen, Désiré, Holvoet, Paul. Effects of Adenovirus-Mediated Human Apo A-I Gene Transfer on Neointima Formation After Endothelial Denudation in Apo E-Deficient Mice. Circulation, vol.96, no.12, 4349-4356.

  129. Quarck, Rozenn, De Geest, Bart, Stengel, Dominique, Mertens, Ann, Lox, Marleen, Theilmeier, Gregor, Michiels, Carine, Raes, Martine, Bult, Hidde, Collen, Désiré, Van Veldhoven, Paul, Ninio, Ewa, Holvoet, Paul. Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor-Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation, vol.103, no.20, 2495-2500.

  130. Toikka, Jyri O, Ahotupa, Markku, Viikari, Jorma S.A, Niinikoski, Harri, Taskinen, Marja-Riitta, Irjala, Kerttu, Hartiala, Jaakko J, Raitakari, Olli T. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis, vol.147, no.1, 133-138.

  131. Desrumaux, Catherine, Deckert, Valérie, Athias, Anne, Masson, David, Lizard, Gérard, Palleau, Viviane, Gambert, Philippe, Lagrost, Laurent. Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering α‐tocopherol to endothelial cells. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.13, no.8, 883-892.

  132. Uittenbogaard, Annette, Shaul, Philip W., Yuhanna, Ivan S., Blair, Alison, Smart, Eric J.. High Density Lipoprotein Prevents Oxidized Low Density Lipoprotein-induced Inhibition of Endothelial Nitric-oxide Synthase Localization and Activation in Caveolae. The Journal of biological chemistry, vol.275, no.15, 11278-11283.

  133. Maier, J.A.M., Barenghi, L., Bradamante, S., Pagani, F.. Modulators of Oxidized LDL-Induced Hyperadhesiveness in Human Endothelial Cells. Biochemical and biophysical research communications, vol.204, no.2, 673-677.

  134. Cockerill, Gillian W., Rye, Kerry-Anne, Gamble, Jennifer R., Vadas, Mathew A., Barter, Philip J.. High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules. Arteriosclerosis, thrombosis, and vascular biology, vol.15, no.11, 1987-1994.

  135. J. Lipid Res. Dhaliwal B. S. 1658 41 2000 10.1016/S0022-2275(20)31999-4 Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로